Mazumdar-Shaw joins Board of Trustees of Memorial Sloan Kettering Cancer Center
Team Udayavani, Apr 28, 2021, 2:31 PM IST
Bengaluru: Biocon Ltd announced on Wednesday that itsExecutive Chairperson Kiran Mazumdar-Shaw has been appointed to the Boardof Trustees of Memorial Sloan Kettering Cancer Center (MSK), a world leaderin cancer treatment and research, based in New York, the US.
She is among the 52members on the board and will serve for a term of three years with effect from April 14, 2021, the Bengaluru-headquartered company said in a statement.
Mazumdar-Shaw is the first woman of Indian nationality to be appointed for this role, it said.
MSK is ranked as one of the top two hospitals for cancer care in the US for more than 30 years and among the nations top pediatric hospitals for cancer care, according to US News & World Report, the statement said.
It maintains one of the worlds most dynamic programmes of cancer research, with more than 120 research laboratories that are focused on better understanding every type of the disease,it was stated.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Centre releases 15th Finance Commission grant for rural local bodies in Karnataka
Karnataka BJP chief Vijayendra slams Cong govt over Waqf notices to farmers, fund crunch
Cement mixer truck overturns near Ambagilu
BJP stages protest against Karnataka govt over Waqf properties row
Youth attempts suicide after being humiliated in public for wearing ripped jeans in Belthangady
MUST WATCH
Latest Additions
Markets stage sharp recovery; Sensex reclaims 79k level, Nifty surges 557.35 points
UP: 25 people booked for attacking civic officials for encroachment removal
SC transfers cheating case against choreographer Remo D’Souza to Delhi court
Fishing vessel collides with naval platform off Goa coast; 2 fishermen missing
BGT Day 1: Bumrah leads India’s spectacular bowling comeback after batting no-show
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.